- Home
- ATRA vs PYPD Comparison
ATRA vs PYPD Comparison
Compare ATRA & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- PYPD
- Stock Information
- Founded
- ATRA 2012
- PYPD 2008
- Country
- ATRA United States
- PYPD Israel
- Employees
- ATRA N/A
- PYPD N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- PYPD Medical/Dental Instruments
- Sector
- ATRA Health Care
- PYPD Health Care
- Exchange
- ATRA Nasdaq
- PYPD Nasdaq
- Market Cap
- ATRA 40.1M
- PYPD 35.3M
- IPO Year
- ATRA 2014
- PYPD 2020
- Fundamental
- Price
- ATRA $7.94
- PYPD $3.28
- Analyst Decision
- ATRA Buy
- PYPD Strong Buy
- Analyst Count
- ATRA 5
- PYPD 5
- Target Price
- ATRA $17.75
- PYPD $11.40
- AVG Volume (30 Days)
- ATRA 61.5K
- PYPD 1.4M
- Earning Date
- ATRA 08-11-2025
- PYPD 08-13-2025
- Dividend Yield
- ATRA N/A
- PYPD N/A
- EPS Growth
- ATRA N/A
- PYPD N/A
- EPS
- ATRA N/A
- PYPD N/A
- Revenue
- ATRA $199,732,000.00
- PYPD N/A
- Revenue This Year
- ATRA N/A
- PYPD N/A
- Revenue Next Year
- ATRA N/A
- PYPD N/A
- P/E Ratio
- ATRA N/A
- PYPD N/A
- Revenue Growth
- ATRA 475.53
- PYPD N/A
- 52 Week Low
- ATRA $5.01
- PYPD $2.30
- 52 Week High
- ATRA $18.71
- PYPD $4.49
- Technical
- Relative Strength Index (RSI)
- ATRA 48.77
- PYPD 54.91
- Support Level
- ATRA $7.74
- PYPD $3.33
- Resistance Level
- ATRA $9.00
- PYPD $3.71
- Average True Range (ATR)
- ATRA 0.54
- PYPD 0.30
- MACD
- ATRA -0.12
- PYPD 0.01
- Stochastic Oscillator
- ATRA 19.79
- PYPD 43.97
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.